Streptococcus Group A
0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Vaccine
1100%
+ 2 programs with unclassified modality
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Allergy TherapeuticsUK - West Sussex
3 programsGAS Epi Study to Measure Age-Related Antibody Titers to J8 VaccineN/AVaccine1 trial
Incidence of Group A Strep Pharyngitis in School Children in FijiN/A1 trial
Molecular Epidemiology of Streptococcus Pyogenes Among Children in Bamako, MaliN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Allergy TherapeuticsMolecular Epidemiology of Streptococcus Pyogenes Among Children in Bamako, Mali
Allergy TherapeuticsIncidence of Group A Strep Pharyngitis in School Children in Fiji
Allergy TherapeuticsGAS Epi Study to Measure Age-Related Antibody Titers to J8 Vaccine
Clinical Trials (3)
NCT00305123Allergy TherapeuticsMolecular Epidemiology of Streptococcus Pyogenes Among Children in Bamako, Mali
Molecular Epidemiology of Streptococcus Pyogenes Among Children in Bamako, Mali
Start: Apr 2006Est. completion: Sep 2009
N/ACompleted
Incidence of Group A Strep Pharyngitis in School Children in Fiji
Start: Jan 2006Est. completion: Nov 2006
N/ACompleted
GAS Epi Study to Measure Age-Related Antibody Titers to J8 Vaccine
Start: Dec 2005Est. completion: May 2006
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space